Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRISP-1: Diindolylmethane for Low-Grade Cervical Cytological Abnormalities
NCT00462813Phase 3Completed
- Sponsor
- Barts and The London School of Medicine and Dentistry
- Start
- Oct 2004
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 3,3'-diindolylmethane in cervical intraepithelial neoplasia (CIN), sponsored by Barts and The London School of Medicine and Dentistry. Started Oct 2004; status: completed.
02
Drugs
3,3'-diindolylmethane
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT00462813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00462813.